Innovative ideas, strategic collaborations and access to integrated data and state-of-the-art technology will cohesively work to eliminate heart diseases and stroke for families and for future generations.
These are some of the organizations who are helping put a stop to heart diseases and stroke.
AHA Precision Medicine Platform Powered by Amazon Web Services
The American Heart Association (AHA) and Amazon Web Services (AWS) have formed a precision medicine collaboration to revolutionize cardiovascular research and patient care. The platform offers a means to discover new solutions with cardiovascular data that will both accelerate and personalize the prevention and management of heart disease and stroke.
Some of our data collaborators for the AHA Precision Medicine Platform, powered by AWS
AstraZeneca Cedars Sinai Heart Institute Dallas Heart Study Duke Clinical Research Institute Intermountain Medical Center Heart Institute The International Stroke Genetics Consortium National Heart, Lung and Blood Institute (NHLBI) Stanford Cardiovascular Institute
My Research Legacy
The Broad Institute of Harvard and MIT joins the AHA in a new strategic business relationship to create the design and engagement structure for My Research Legacy™.
The Marfan Foundation has agreed to participate in the My Research Legacy pilot and will help identify individuals less than 50 years of age who have suffered an aortic dissection. Marfan syndrome is a life-threatening genetic disorder, and an early, accurate diagnosis is essential, not only for people with Marfan syndrome, but also for those with related disorders. Knowing the signs can save lives.
One Brave Idea
The American Heart Association and Verily, with support from AstraZeneca, collectively committed $75 million, and guidance, mentorship and resources over at least five years to support a groundbreaking research idea aimed at preventing or reversing coronary heart disease and, ultimately, improving and restoring cardiovascular health.